Related Experiment Video
Updated: May 10, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease
Dongfang Su1, Zhongxia Li, Xinrui Li
1Guangdong Provincial Key Laboratory of Food, Nutrition, and Health, Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China.
Insights
Elevated serum interleukin-6 (IL-6) levels significantly increase mortality risk in coronary artery disease (CAD) patients. This finding highlights IL-6 as a potential biomarker for cardiovascular disease prognosis.
Area of Science:
- Cardiovascular Medicine
- Biomarkers
- Inflammation Research
Background:
- Coronary artery disease (CAD) poses a significant global health burden.
- Inflammatory markers, such as interleukin-6 (IL-6), are increasingly recognized for their role in cardiovascular pathophysiology.
- Understanding the prognostic value of IL-6 in CAD patients is crucial for risk stratification.
Purpose of the Study:
- To investigate the association between serum interleukin-6 (IL-6) levels and the risk of all-cause and cardiovascular mortality in patients with coronary artery disease (CAD).
Main Methods:
- A prospective cohort study was conducted with 718 CAD patients from the Guangzhou Cardiovascular Disease Cohort (GCDC).
- Multivariable-adjusted Cox proportional hazards regression analyses were employed to assess the relationship between serum IL-6 and mortality outcomes.
- Follow-up data were collected over 1663 person-years.
Main Results:
- A one-standard deviation increase in log-transformed serum IL-6 was associated with significantly increased risks of all-cause (HR 2.93) and cardiovascular mortality (HR 2.04).
- Patients in the highest serum IL-6 tertile exhibited substantially higher risks for all-cause (HR 17.12) and cardiovascular mortality (HR 8.68) compared to the lowest tertile.
- These associations remained significant after multivariable adjustment, particularly in male patients.
Conclusions:
- Serum interleukin-6 (IL-6) is a significant independent predictor of both all-cause and cardiovascular mortality in hospitalized patients with coronary artery disease (CAD).
- IL-6 may serve as a valuable prognostic biomarker for identifying high-risk CAD patients.
Objectives:
To evaluate whether serum interleukin-6 (IL-6) is associated with increased risk of mortality in coronary artery disease (CAD) patients.
Methods:
We performed a prospective cohort study of 718 CAD patients from the Guangzhou Cardiovascular Disease Cohort (GCDC) study. Multivariable-adjusted Cox proportional hazards regression analyses were used to examine the association between serum IL-6 with all-cause and cardiovascular mortality.
Results:
During the 1663 person-years of followup, the cumulative all-cause mortality and cardiovascular mortality were 6.5% (n = 47) and 3.3% (n = 24), respectively. The mean length of followup was 2.32 ± 0.81 years. In the multivariable analyses, a one-SD increment in log-transformed serum IL-6 was positively associated with an increased risk of all-cause and cardiovascular mortality, with hazard ratios (HR) of 2.93 (95% CI, 2.11-4.08) and 2.04 (95% CI, 1.34-3.68) within the patients combined and 2.98 (95% CI, 2.12-4.18) and 3.10 (95% CI, 1.98-4.85) within males, respectively. Patients in the highest serum IL-6 tertile versus the lowest tertile were at higher risk of all-cause and cardiovascular mortality, with HR of 17.12 (95% CI 3.11-71.76) and 8.68 (95% CI, 1.88-37.51), respectively.
Conclusions:
In hospitalized patients with CAD, serum IL-6 is significantly associated with all-cause and cardiovascular mortality.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease III: Clinical Manifestations
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
